Keywords: novartis, money-back, campaign, diovan, swiss, drug, major

Novartis in "money-back" US campaign for Diovan

Article | 03 May 2004

Print This

Swiss drug major Novartis has unveiled a novel marketing initiative in the very competitive US market for its top-selling antihypertensive ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in